▶ 調査レポート

ナルメフェンのグローバル市場インサイト・予測(~2027年)

• 英文タイトル:Global Nalmefene Market Insights and Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。ナルメフェンのグローバル市場インサイト・予測(~2027年) / Global Nalmefene Market Insights and Forecast to 2027 / QY2112C00549資料のイメージです。• レポートコード:QY2112C00549
• 出版社/出版日:QYResearch / 2021年12月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、125ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Multi User¥1,102,500 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,470,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料はナルメフェンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。ナルメフェンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(98%以下、98%〜99%、99%以上)、用途別市場規模(中枢神経系疾患治療、呼吸器疾患治療、急性中毒治療、その他)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・ナルメフェンの世界市場概要
・メーカー別の競争状況、市場シェア
・ナルメフェンの種類別市場規模:98%以下、98%〜99%、99%以上
・ナルメフェンの用途別市場規模:中枢神経系疾患治療、呼吸器疾患治療、急性中毒治療、その他
・北米のナルメフェン市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパのナルメフェン市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアのナルメフェン市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米のナルメフェン市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカのナルメフェン市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:CarboMer、Tocris Bioscience、Biosynth Carbosynth、AK Scientific Inc、Toronto Research Chemicals、Alfa Chemistry、Standardpharm Co., Ltd、PI Chemicals Ltd、DC Chemicals、OChem Incorporation、THE BioTek、Shenzhen Polymer Biochemical Technology Co., LTD、Bailingwei Technology Co., LTD、Shanghai Xi Yuan Biological Technology Co., LTD、Anhui Zisheng Technology Co., LTD
・ナルメフェンのバリューチェーン・販売チャネル分析
・ナルメフェンの世界市場動向

As a specific morphine receptor blocker, Nalmefene is a 6-methylene analogues of Naltrexone, which has gradually become a substitute for naloxone.

Market Analysis and Insights: Global Nalmefene Market
The global Nalmefene market is valued at US$ million in 2020. The market size will reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.

Global Nalmefene Scope and Segment
Nalmefene market is segmented by Purity, and by Application. Players, stakeholders, and other participants in the global Nalmefene market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Purity and by Application for the period 2016-2027.

Segment by Purity
Less than 98%
98% to 99%
More than 99%

Segment by Application
Treatment of Central Nervous System Diseases
Treatment of Respiratory Diseases
Treatment of Acute Poisoning
Others

By Company
CarboMer
Tocris Bioscience
Biosynth Carbosynth
AK Scientific Inc
Toronto Research Chemicals
Alfa Chemistry
Standardpharm Co., Ltd
PI Chemicals Ltd
DC Chemicals
OChem Incorporation
THE BioTek
Shenzhen Polymer Biochemical Technology Co., LTD
Bailingwei Technology Co., LTD
Shanghai Xi Yuan Biological Technology Co., LTD
Anhui Zisheng Technology Co., LTD

Production by Region
North America
Europe
China
Japan

Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Nalmefene Product Introduction
1.2 Market by Purity
1.2.1 Global Nalmefene Market Size Growth Rate by Purity
1.2.2 Less than 98%
1.2.3 98% to 99%
1.2.4 More than 99%
1.3 Market by Application
1.3.1 Global Nalmefene Market Size Growth Rate by Application
1.3.2 Treatment of Central Nervous System Diseases
1.3.3 Treatment of Respiratory Diseases
1.3.4 Treatment of Acute Poisoning
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Nalmefene Production
2.1 Global Nalmefene Production Capacity (2016-2027)
2.2 Global Nalmefene Production by Region: 2016 VS 2021 VS 2027
2.3 Global Nalmefene Production by Region
2.3.1 Global Nalmefene Historic Production by Region (2016-2021)
2.3.2 Global Nalmefene Forecasted Production by Region (2022-2027)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan

3 Global Nalmefene Sales in Volume & Value Estimates and Forecasts
3.1 Global Nalmefene Sales Estimates and Forecasts 2016-2027
3.2 Global Nalmefene Revenue Estimates and Forecasts 2016-2027
3.3 Global Nalmefene Revenue by Region: 2016 VS 2021 VS 2027
3.4 Global Top Nalmefene Regions by Sales
3.4.1 Global Top Nalmefene Regions by Sales (2016-2021)
3.4.2 Global Top Nalmefene Regions by Sales (2022-2027)
3.5 Global Top Nalmefene Regions by Revenue
3.5.1 Global Top Nalmefene Regions by Revenue (2016-2021)
3.5.2 Global Top Nalmefene Regions by Revenue (2022-2027)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa

4 Competition by Manufactures
4.1 Global Nalmefene Production Capacity by Manufacturers
4.2 Global Nalmefene Sales by Manufacturers
4.2.1 Global Top Nalmefene Manufacturers by Sales (2016-2021)
4.2.2 Global Top Nalmefene Manufacturers Market Share by Sales (2016-2021)
4.2.3 Global Top 10 and Top 5 Companies by Nalmefene Sales in 2020
4.3 Global Nalmefene Revenue by Manufacturers
4.3.1 Global Top Nalmefene Manufacturers by Revenue (2016-2021)
4.3.2 Global Top Nalmefene Manufacturers Market Share by Revenue (2016-2021)
4.3.3 Global Top 10 and Top 5 Companies by Nalmefene Revenue in 2020
4.4 Global Nalmefene Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Nalmefene Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Nalmefene Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type
5.1 Global Nalmefene Sales by Purity
5.1.1 Global Nalmefene Historical Sales by Purity (2016-2021)
5.1.2 Global Nalmefene Forecasted Sales by Purity (2022-2027)
5.1.3 Global Nalmefene Sales Market Share by Purity (2016-2027)
5.2 Global Nalmefene Revenue by Purity
5.2.1 Global Nalmefene Historical Revenue by Purity (2016-2021)
5.2.2 Global Nalmefene Forecasted Revenue by Purity (2022-2027)
5.2.3 Global Nalmefene Revenue Market Share by Purity (2016-2027)
5.3 Global Nalmefene Price by Purity
5.3.1 Global Nalmefene Price by Purity (2016-2021)
5.3.2 Global Nalmefene Price Forecast by Purity (2022-2027)

6 Market Size by Application
6.1 Global Nalmefene Sales by Application
6.1.1 Global Nalmefene Historical Sales by Application (2016-2021)
6.1.2 Global Nalmefene Forecasted Sales by Application (2022-2027)
6.1.3 Global Nalmefene Sales Market Share by Application (2016-2027)
6.2 Global Nalmefene Revenue by Application
6.2.1 Global Nalmefene Historical Revenue by Application (2016-2021)
6.2.2 Global Nalmefene Forecasted Revenue by Application (2022-2027)
6.2.3 Global Nalmefene Revenue Market Share by Application (2016-2027)
6.3 Global Nalmefene Price by Application
6.3.1 Global Nalmefene Price by Application (2016-2021)
6.3.2 Global Nalmefene Price Forecast by Application (2022-2027)

7 North America
7.1 North America Nalmefene Market Size by Purity
7.1.1 North America Nalmefene Sales by Purity (2016-2027)
7.1.2 North America Nalmefene Revenue by Purity (2016-2027)
7.2 North America Nalmefene Market Size by Application
7.2.1 North America Nalmefene Sales by Application (2016-2027)
7.2.2 North America Nalmefene Revenue by Application (2016-2027)
7.3 North America Nalmefene Sales by Country
7.3.1 North America Nalmefene Sales by Country (2016-2027)
7.3.2 North America Nalmefene Revenue by Country (2016-2027)
7.3.3 United States
7.3.4 Canada

8 Europe
8.1 Europe Nalmefene Market Size by Purity
8.1.1 Europe Nalmefene Sales by Purity (2016-2027)
8.1.2 Europe Nalmefene Revenue by Purity (2016-2027)
8.2 Europe Nalmefene Market Size by Application
8.2.1 Europe Nalmefene Sales by Application (2016-2027)
8.2.2 Europe Nalmefene Revenue by Application (2016-2027)
8.3 Europe Nalmefene Sales by Country
8.3.1 Europe Nalmefene Sales by Country (2016-2027)
8.3.2 Europe Nalmefene Revenue by Country (2016-2027)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia

9 Asia Pacific
9.1 Asia Pacific Nalmefene Market Size by Purity
9.1.1 Asia Pacific Nalmefene Sales by Purity (2016-2027)
9.1.2 Asia Pacific Nalmefene Revenue by Purity (2016-2027)
9.2 Asia Pacific Nalmefene Market Size by Application
9.2.1 Asia Pacific Nalmefene Sales by Application (2016-2027)
9.2.2 Asia Pacific Nalmefene Revenue by Application (2016-2027)
9.3 Asia Pacific Nalmefene Sales by Region
9.3.1 Asia Pacific Nalmefene Sales by Region (2016-2027)
9.3.2 Asia Pacific Nalmefene Revenue by Region (2016-2027)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia

10 Latin America
10.1 Latin America Nalmefene Market Size by Purity
10.1.1 Latin America Nalmefene Sales by Purity (2016-2027)
10.1.2 Latin America Nalmefene Revenue by Purity (2016-2027)
10.2 Latin America Nalmefene Market Size by Application
10.2.1 Latin America Nalmefene Sales by Application (2016-2027)
10.2.2 Latin America Nalmefene Revenue by Application (2016-2027)
10.3 Latin America Nalmefene Sales by Country
10.3.1 Latin America Nalmefene Sales by Country (2016-2027)
10.3.2 Latin America Nalmefene Revenue by Country (2016-2027)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Nalmefene Market Size by Purity
11.1.1 Middle East and Africa Nalmefene Sales by Purity (2016-2027)
11.1.2 Middle East and Africa Nalmefene Revenue by Purity (2016-2027)
11.2 Middle East and Africa Nalmefene Market Size by Application
11.2.1 Middle East and Africa Nalmefene Sales by Application (2016-2027)
11.2.2 Middle East and Africa Nalmefene Revenue by Application (2016-2027)
11.3 Middle East and Africa Nalmefene Sales by Country
11.3.1 Middle East and Africa Nalmefene Sales by Country (2016-2027)
11.3.2 Middle East and Africa Nalmefene Revenue by Country (2016-2027)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE

12 Corporate Profiles
12.1 CarboMer
12.1.1 CarboMer Corporation Information
12.1.2 CarboMer Overview
12.1.3 CarboMer Nalmefene Sales, Price, Revenue and Gross Margin (2016-2021)
12.1.4 CarboMer Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 CarboMer Recent Developments
12.2 Tocris Bioscience
12.2.1 Tocris Bioscience Corporation Information
12.2.2 Tocris Bioscience Overview
12.2.3 Tocris Bioscience Nalmefene Sales, Price, Revenue and Gross Margin (2016-2021)
12.2.4 Tocris Bioscience Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Tocris Bioscience Recent Developments
12.3 Biosynth Carbosynth
12.3.1 Biosynth Carbosynth Corporation Information
12.3.2 Biosynth Carbosynth Overview
12.3.3 Biosynth Carbosynth Nalmefene Sales, Price, Revenue and Gross Margin (2016-2021)
12.3.4 Biosynth Carbosynth Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Biosynth Carbosynth Recent Developments
12.4 AK Scientific Inc
12.4.1 AK Scientific Inc Corporation Information
12.4.2 AK Scientific Inc Overview
12.4.3 AK Scientific Inc Nalmefene Sales, Price, Revenue and Gross Margin (2016-2021)
12.4.4 AK Scientific Inc Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 AK Scientific Inc Recent Developments
12.5 Toronto Research Chemicals
12.5.1 Toronto Research Chemicals Corporation Information
12.5.2 Toronto Research Chemicals Overview
12.5.3 Toronto Research Chemicals Nalmefene Sales, Price, Revenue and Gross Margin (2016-2021)
12.5.4 Toronto Research Chemicals Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Toronto Research Chemicals Recent Developments
12.6 Alfa Chemistry
12.6.1 Alfa Chemistry Corporation Information
12.6.2 Alfa Chemistry Overview
12.6.3 Alfa Chemistry Nalmefene Sales, Price, Revenue and Gross Margin (2016-2021)
12.6.4 Alfa Chemistry Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Alfa Chemistry Recent Developments
12.7 Standardpharm Co., Ltd
12.7.1 Standardpharm Co., Ltd Corporation Information
12.7.2 Standardpharm Co., Ltd Overview
12.7.3 Standardpharm Co., Ltd Nalmefene Sales, Price, Revenue and Gross Margin (2016-2021)
12.7.4 Standardpharm Co., Ltd Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Standardpharm Co., Ltd Recent Developments
12.8 PI Chemicals Ltd
12.8.1 PI Chemicals Ltd Corporation Information
12.8.2 PI Chemicals Ltd Overview
12.8.3 PI Chemicals Ltd Nalmefene Sales, Price, Revenue and Gross Margin (2016-2021)
12.8.4 PI Chemicals Ltd Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 PI Chemicals Ltd Recent Developments
12.9 DC Chemicals
12.9.1 DC Chemicals Corporation Information
12.9.2 DC Chemicals Overview
12.9.3 DC Chemicals Nalmefene Sales, Price, Revenue and Gross Margin (2016-2021)
12.9.4 DC Chemicals Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 DC Chemicals Recent Developments
12.10 OChem Incorporation
12.10.1 OChem Incorporation Corporation Information
12.10.2 OChem Incorporation Overview
12.10.3 OChem Incorporation Nalmefene Sales, Price, Revenue and Gross Margin (2016-2021)
12.10.4 OChem Incorporation Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 OChem Incorporation Recent Developments
12.11 THE BioTek
12.11.1 THE BioTek Corporation Information
12.11.2 THE BioTek Overview
12.11.3 THE BioTek Nalmefene Sales, Price, Revenue and Gross Margin (2016-2021)
12.11.4 THE BioTek Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 THE BioTek Recent Developments
12.12 Shenzhen Polymer Biochemical Technology Co., LTD
12.12.1 Shenzhen Polymer Biochemical Technology Co., LTD Corporation Information
12.12.2 Shenzhen Polymer Biochemical Technology Co., LTD Overview
12.12.3 Shenzhen Polymer Biochemical Technology Co., LTD Nalmefene Sales, Price, Revenue and Gross Margin (2016-2021)
12.12.4 Shenzhen Polymer Biochemical Technology Co., LTD Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Shenzhen Polymer Biochemical Technology Co., LTD Recent Developments
12.13 Bailingwei Technology Co., LTD
12.13.1 Bailingwei Technology Co., LTD Corporation Information
12.13.2 Bailingwei Technology Co., LTD Overview
12.13.3 Bailingwei Technology Co., LTD Nalmefene Sales, Price, Revenue and Gross Margin (2016-2021)
12.13.4 Bailingwei Technology Co., LTD Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Bailingwei Technology Co., LTD Recent Developments
12.14 Shanghai Xi Yuan Biological Technology Co., LTD
12.14.1 Shanghai Xi Yuan Biological Technology Co., LTD Corporation Information
12.14.2 Shanghai Xi Yuan Biological Technology Co., LTD Overview
12.14.3 Shanghai Xi Yuan Biological Technology Co., LTD Nalmefene Sales, Price, Revenue and Gross Margin (2016-2021)
12.14.4 Shanghai Xi Yuan Biological Technology Co., LTD Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Shanghai Xi Yuan Biological Technology Co., LTD Recent Developments
12.15 Anhui Zisheng Technology Co., LTD
12.15.1 Anhui Zisheng Technology Co., LTD Corporation Information
12.15.2 Anhui Zisheng Technology Co., LTD Overview
12.15.3 Anhui Zisheng Technology Co., LTD Nalmefene Sales, Price, Revenue and Gross Margin (2016-2021)
12.15.4 Anhui Zisheng Technology Co., LTD Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Anhui Zisheng Technology Co., LTD Recent Developments

13 Industry Chain and Sales Channels Analysis
13.1 Nalmefene Industry Chain Analysis
13.2 Nalmefene Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Nalmefene Production Mode & Process
13.4 Nalmefene Sales and Marketing
13.4.1 Nalmefene Sales Channels
13.4.2 Nalmefene Distributors
13.5 Nalmefene Customers

14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Nalmefene Industry Trends
14.2 Nalmefene Market Drivers
14.3 Nalmefene Market Challenges
14.4 Nalmefene Market Restraints

15 Key Finding in The Global Nalmefene Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Nalmefene Market Size Growth Rate by Purity, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Less than 98%
Table 3. Major Manufacturers of 98% to 99%
Table 4. Major Manufacturers of More than 99%
Table 5. Global Nalmefene Market Size Growth Rate by Application, 2016 VS 2021 2027 (US$ Million)
Table 6. Global Nalmefene Production by Region: 2016 VS 2021 VS 2027 (Kg)
Table 7. Global Nalmefene Production by Region (2016-2021) & (Kg)
Table 8. Global Nalmefene Production Market Share by Region (2016-2021)
Table 9. Global Nalmefene Production by Region (2022-2027) & (Kg)
Table 10. Global Nalmefene Production Market Share by Region (2022-2027)
Table 11. Global Nalmefene Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 12. Global Nalmefene Sales by Region (2016-2021) & (Kg)
Table 13. Global Nalmefene Sales Market Share by Region (2016-2021)
Table 14. Global Nalmefene Sales by Region (2022-2027) & (Kg)
Table 15. Global Nalmefene Sales Market Share by Region (2022-2027)
Table 16. Global Nalmefene Revenue by Region (2016-2021) & (US$ Million)
Table 17. Global Nalmefene Revenue Market Share by Region (2016-2021)
Table 18. Global Nalmefene Revenue by Region (2022-2027) & (US$ Million)
Table 19. Global Nalmefene Revenue Market Share by Region (2022-2027)
Table 20. Global Nalmefene Production Capacity by Manufacturers (2016-2021) & (Kg)
Table 21. Global Nalmefene Capacity Market Share by Manufacturers (2016-2021)
Table 22. Global Nalmefene Production by Manufacturers (2016-2021) & (Kg)
Table 23. Global Nalmefene Production Market Share by Manufacturers (2016-2021)
Table 24. Global Nalmefene Sales by Manufacturers (2016-2021) & (Kg)
Table 25. Global Nalmefene Sales Share by Manufacturers (2016-2021)
Table 26. Global Nalmefene Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 27. Global Nalmefene Revenue Share by Manufacturers (2016-2021)
Table 28. Nalmefene Price by Manufacturers 2016-2021 (US$/g)
Table 29. Global Nalmefene Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Nalmefene by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nalmefene as of 2020)
Table 31. Nalmefene Manufacturing Base Distribution and Headquarters
Table 32. Manufacturers Nalmefene Product Offered
Table 33. Date of Manufacturers Enter into Nalmefene Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Nalmefene Sales by Purity (2016-2021) & (Kg)
Table 36. Global Nalmefene Sales by Purity (2022-2027) & (Kg)
Table 37. Global Nalmefene Sales Share by Purity (2016-2021)
Table 38. Global Nalmefene Sales Share by Purity (2022-2027)
Table 39. Global Nalmefene Revenue by Purity (2016-2021) & (US$ Million)
Table 40. Global Nalmefene Revenue by Purity (2022-2027) & (US$ Million)
Table 41. Global Nalmefene Revenue Share by Purity (2016-2021)
Table 42. Global Nalmefene Revenue Share by Purity (2022-2027)
Table 43. Nalmefene Price by Purity (2016-2021) & (US$/g)
Table 44. Global Nalmefene Price Forecast by Purity (2022-2027) & (US$/g)
Table 45. Global Nalmefene Sales by Application (2016-2021) & (Kg)
Table 46. Global Nalmefene Sales by Application (2022-2027) & (Kg)
Table 47. Global Nalmefene Sales Share by Application (2016-2021)
Table 48. Global Nalmefene Sales Share by Application (2022-2027)
Table 49. Global Nalmefene Revenue by Application (2016-2021) & (US$ Million)
Table 50. Global Nalmefene Revenue by Application (2022-2027) & (US$ Million)
Table 51. Global Nalmefene Revenue Share by Application (2016-2021)
Table 52. Global Nalmefene Revenue Share by Application (2022-2027)
Table 53. Nalmefene Price by Application (2016-2021) & (US$/g)
Table 54. Global Nalmefene Price Forecast by Application (2022-2027) & (US$/g)
Table 55. North America Nalmefene Sales by Purity (2016-2021) & (Kg)
Table 56. North America Nalmefene Sales by Purity (2022-2027) & (Kg)
Table 57. North America Nalmefene Revenue by Purity (2016-2021) & (US$ Million)
Table 58. North America Nalmefene Revenue by Purity (2022-2027) & (US$ Million)
Table 59. North America Nalmefene Sales by Application (2016-2021) & (Kg)
Table 60. North America Nalmefene Sales by Application (2022-2027) & (Kg)
Table 61. North America Nalmefene Revenue by Application (2016-2021) & (US$ Million)
Table 62. North America Nalmefene Revenue by Application (2022-2027) & (US$ Million)
Table 63. North America Nalmefene Sales by Country (2016-2021) & (Kg)
Table 64. North America Nalmefene Sales by Country (2022-2027) & (Kg)
Table 65. North America Nalmefene Revenue by Country (2016-2021) & (US$ Million)
Table 66. North America Nalmefene Revenue by Country (2022-2027) & (US$ Million)
Table 67. Europe Nalmefene Sales by Purity (2016-2021) & (Kg)
Table 68. Europe Nalmefene Sales by Purity (2022-2027) & (Kg)
Table 69. Europe Nalmefene Revenue by Purity (2016-2021) & (US$ Million)
Table 70. Europe Nalmefene Revenue by Purity (2022-2027) & (US$ Million)
Table 71. Europe Nalmefene Sales by Application (2016-2021) & (Kg)
Table 72. Europe Nalmefene Sales by Application (2022-2027) & (Kg)
Table 73. Europe Nalmefene Revenue by Application (2016-2021) & (US$ Million)
Table 74. Europe Nalmefene Revenue by Application (2022-2027) & (US$ Million)
Table 75. Europe Nalmefene Sales by Country (2016-2021) & (Kg)
Table 76. Europe Nalmefene Sales by Country (2022-2027) & (Kg)
Table 77. Europe Nalmefene Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Nalmefene Revenue by Country (2022-2027) & (US$ Million)
Table 79. Asia Pacific Nalmefene Sales by Purity (2016-2021) & (Kg)
Table 80. Asia Pacific Nalmefene Sales by Purity (2022-2027) & (Kg)
Table 81. Asia Pacific Nalmefene Revenue by Purity (2016-2021) & (US$ Million)
Table 82. Asia Pacific Nalmefene Revenue by Purity (2022-2027) & (US$ Million)
Table 83. Asia Pacific Nalmefene Sales by Application (2016-2021) & (Kg)
Table 84. Asia Pacific Nalmefene Sales by Application (2022-2027) & (Kg)
Table 85. Asia Pacific Nalmefene Revenue by Application (2016-2021) & (US$ Million)
Table 86. Asia Pacific Nalmefene Revenue by Application (2022-2027) & (US$ Million)
Table 87. Asia Pacific Nalmefene Sales by Region (2016-2021) & (Kg)
Table 88. Asia Pacific Nalmefene Sales by Region (2022-2027) & (Kg)
Table 89. Asia Pacific Nalmefene Revenue by Region (2016-2021) & (US$ Million)
Table 90. Asia Pacific Nalmefene Revenue by Region (2022-2027) & (US$ Million)
Table 91. Latin America Nalmefene Sales by Purity (2016-2021) & (Kg)
Table 92. Latin America Nalmefene Sales by Purity (2022-2027) & (Kg)
Table 93. Latin America Nalmefene Revenue by Purity (2016-2021) & (US$ Million)
Table 94. Latin America Nalmefene Revenue by Purity (2022-2027) & (US$ Million)
Table 95. Latin America Nalmefene Sales by Application (2016-2021) & (Kg)
Table 96. Latin America Nalmefene Sales by Application (2022-2027) & (Kg)
Table 97. Latin America Nalmefene Revenue by Application (2016-2021) & (US$ Million)
Table 98. Latin America Nalmefene Revenue by Application (2022-2027) & (US$ Million)
Table 99. Latin America Nalmefene Sales by Country (2016-2021) & (Kg)
Table 100. Latin America Nalmefene Sales by Country (2022-2027) & (Kg)
Table 101. Latin America Nalmefene Revenue by Country (2016-2021) & (US$ Million)
Table 102. Latin America Nalmefene Revenue by Country (2022-2027) & (US$ Million)
Table 103. Middle East and Africa Nalmefene Sales by Purity (2016-2021) & (Kg)
Table 104. Middle East and Africa Nalmefene Sales by Purity (2022-2027) & (Kg)
Table 105. Middle East and Africa Nalmefene Revenue by Purity (2016-2021) & (US$ Million)
Table 106. Middle East and Africa Nalmefene Revenue by Purity (2022-2027) & (US$ Million)
Table 107. Middle East and Africa Nalmefene Sales by Application (2016-2021) & (Kg)
Table 108. Middle East and Africa Nalmefene Sales by Application (2022-2027) & (Kg)
Table 109. Middle East and Africa Nalmefene Revenue by Application (2016-2021) & (US$ Million)
Table 110. Middle East and Africa Nalmefene Revenue by Application (2022-2027) & (US$ Million)
Table 111. Middle East and Africa Nalmefene Sales by Country (2016-2021) & (Kg)
Table 112. Middle East and Africa Nalmefene Sales by Country (2022-2027) & (Kg)
Table 113. Middle East and Africa Nalmefene Revenue by Country (2016-2021) & (US$ Million)
Table 114. Middle East and Africa Nalmefene Revenue by Country (2022-2027) & (US$ Million)
Table 115. CarboMer Corporation Information
Table 116. CarboMer Description and Major Businesses
Table 117. CarboMer Nalmefene Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 118. CarboMer Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. CarboMer Recent Development
Table 120. Tocris Bioscience Corporation Information
Table 121. Tocris Bioscience Description and Major Businesses
Table 122. Tocris Bioscience Nalmefene Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 123. Tocris Bioscience Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Tocris Bioscience Recent Development
Table 125. Biosynth Carbosynth Corporation Information
Table 126. Biosynth Carbosynth Description and Major Businesses
Table 127. Biosynth Carbosynth Nalmefene Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 128. Biosynth Carbosynth Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Biosynth Carbosynth Recent Development
Table 130. AK Scientific Inc Corporation Information
Table 131. AK Scientific Inc Description and Major Businesses
Table 132. AK Scientific Inc Nalmefene Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 133. AK Scientific Inc Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. AK Scientific Inc Recent Development
Table 135. Toronto Research Chemicals Corporation Information
Table 136. Toronto Research Chemicals Description and Major Businesses
Table 137. Toronto Research Chemicals Nalmefene Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 138. Toronto Research Chemicals Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Toronto Research Chemicals Recent Development
Table 140. Alfa Chemistry Corporation Information
Table 141. Alfa Chemistry Description and Major Businesses
Table 142. Alfa Chemistry Nalmefene Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 143. Alfa Chemistry Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Alfa Chemistry Recent Development
Table 145. Standardpharm Co., Ltd Corporation Information
Table 146. Standardpharm Co., Ltd Description and Major Businesses
Table 147. Standardpharm Co., Ltd Nalmefene Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 148. Standardpharm Co., Ltd Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Standardpharm Co., Ltd Recent Development
Table 150. PI Chemicals Ltd Corporation Information
Table 151. PI Chemicals Ltd Description and Major Businesses
Table 152. PI Chemicals Ltd Nalmefene Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 153. PI Chemicals Ltd Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. PI Chemicals Ltd Recent Development
Table 155. DC Chemicals Corporation Information
Table 156. DC Chemicals Description and Major Businesses
Table 157. DC Chemicals Nalmefene Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 158. DC Chemicals Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. DC Chemicals Recent Development
Table 160. OChem Incorporation Corporation Information
Table 161. OChem Incorporation Description and Major Businesses
Table 162. OChem Incorporation Nalmefene Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 163. OChem Incorporation Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. OChem Incorporation Recent Development
Table 165. THE BioTek Corporation Information
Table 166. THE BioTek Description and Major Businesses
Table 167. THE BioTek Nalmefene Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 168. THE BioTek Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. THE BioTek Recent Development
Table 170. Shenzhen Polymer Biochemical Technology Co., LTD Corporation Information
Table 171. Shenzhen Polymer Biochemical Technology Co., LTD Description and Major Businesses
Table 172. Shenzhen Polymer Biochemical Technology Co., LTD Nalmefene Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 173. Shenzhen Polymer Biochemical Technology Co., LTD Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Shenzhen Polymer Biochemical Technology Co., LTD Recent Development
Table 175. Bailingwei Technology Co., LTD Corporation Information
Table 176. Bailingwei Technology Co., LTD Description and Major Businesses
Table 177. Bailingwei Technology Co., LTD Nalmefene Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 178. Bailingwei Technology Co., LTD Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
Table 179. Bailingwei Technology Co., LTD Recent Development
Table 180. Shanghai Xi Yuan Biological Technology Co., LTD Corporation Information
Table 181. Shanghai Xi Yuan Biological Technology Co., LTD Description and Major Businesses
Table 182. Shanghai Xi Yuan Biological Technology Co., LTD Nalmefene Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 183. Shanghai Xi Yuan Biological Technology Co., LTD Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
Table 184. Shanghai Xi Yuan Biological Technology Co., LTD Recent Development
Table 185. Anhui Zisheng Technology Co., LTD Corporation Information
Table 186. Anhui Zisheng Technology Co., LTD Description and Major Businesses
Table 187. Anhui Zisheng Technology Co., LTD Nalmefene Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2016-2021)
Table 188. Anhui Zisheng Technology Co., LTD Nalmefene Product Model Numbers, Pictures, Descriptions and Specifications
Table 189. Anhui Zisheng Technology Co., LTD Recent Development
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Nalmefene Distributors List
Table 193. Nalmefene Customers List
Table 194. Nalmefene Market Trends
Table 195. Nalmefene Market Drivers
Table 196. Nalmefene Market Challenges
Table 197. Nalmefene Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Nalmefene Product Picture
Figure 2. Global Nalmefene Market Share by Purity in 2020 & 2027
Figure 3. Less than 98% Product Picture
Figure 4. 98% to 99% Product Picture
Figure 5. More than 99% Product Picture
Figure 6. Global Nalmefene Market Share by Application in 2020 & 2027
Figure 7. Treatment of Central Nervous System Diseases
Figure 8. Treatment of Respiratory Diseases
Figure 9. Treatment of Acute Poisoning
Figure 10. Others
Figure 11. Nalmefene Report Years Considered
Figure 12. Global Nalmefene Capacity, Production and Utilization (2016-2027) & (Kg)
Figure 13. Global Nalmefene Production Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Nalmefene Production Market Share by Region (2016-2021)
Figure 15. Global Nalmefene Production Market Share by Region (2022-2027)
Figure 16. Nalmefene Production Growth Rate in North America (2016-2027) & (Kg)
Figure 17. Nalmefene Production Growth Rate in Europe (2016-2027) & (Kg)
Figure 18. Nalmefene Production Growth Rate in China (2016-2027) & (Kg)
Figure 19. Nalmefene Production Growth Rate in Japan (2016-2027) & (Kg)
Figure 20. Global Nalmefene Sales 2016-2027 (Kg)
Figure 21. Global Nalmefene Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 22. Global Nalmefene Revenue 2016-2027 (US$ Million)
Figure 23. Global Nalmefene Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 24. Global Nalmefene Sales Market Share by Region (2016-2021)
Figure 25. Global Nalmefene Sales Market Share by Region (2022-2027)
Figure 26. North America Nalmefene Sales YoY (2016-2027) & (Kg)
Figure 27. North America Nalmefene Revenue YoY (2016-2027) & (US$ Million)
Figure 28. Europe Nalmefene Sales YoY (2016-2027) & (Kg)
Figure 29. Europe Nalmefene Revenue YoY (2016-2027) & (US$ Million)
Figure 30. Asia-Pacific Nalmefene Sales YoY (2016-2027) & (Kg)
Figure 31. Asia-Pacific Nalmefene Revenue YoY (2016-2027) & (US$ Million)
Figure 32. Latin America Nalmefene Sales YoY (2016-2027) & (Kg)
Figure 33. Latin America Nalmefene Revenue YoY (2016-2027) & (US$ Million)
Figure 34. Middle East & Africa Nalmefene Sales YoY (2016-2027) & (Kg)
Figure 35. Middle East & Africa Nalmefene Revenue YoY (2016-2027) & (US$ Million)
Figure 36. The Top 10 and Top 5 Players Market Share by Nalmefene Sales in 2020
Figure 37. The Top 10 and Top 5 Players Market Share by Nalmefene Revenue in 2020
Figure 38. Nalmefene Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 39. Global Nalmefene Sales Market Share by Purity (2016-2027)
Figure 40. Global Nalmefene Revenue Market Share by Purity (2016-2027)
Figure 41. Global Nalmefene Sales Market Share by Application (2016-2027)
Figure 42. Global Nalmefene Revenue Market Share by Application (2016-2027)
Figure 43. North America Nalmefene Sales Market Share by Purity (2016-2027)
Figure 44. North America Nalmefene Revenue Market Share by Purity (2016-2027)
Figure 45. North America Nalmefene Sales Market Share by Application (2016-2027)
Figure 46. North America Nalmefene Revenue Market Share by Application (2016-2027)
Figure 47. North America Nalmefene Sales Share by Country (2016-2027)
Figure 48. North America Nalmefene Revenue Share by Country (2016-2027)
Figure 49. United States Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 50. Canada Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 51. Europe Nalmefene Sales Market Share by Purity (2016-2027)
Figure 52. Europe Nalmefene Revenue Market Share by Purity (2016-2027)
Figure 53. Europe Nalmefene Sales Market Share by Application (2016-2027)
Figure 54. Europe Nalmefene Revenue Market Share by Application (2016-2027)
Figure 55. Europe Nalmefene Sales Share by Country (2016-2027)
Figure 56. Europe Nalmefene Revenue Share by Country (2016-2027)
Figure 57. Germany Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 58. France Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 59. U.K. Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 60. Italy Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 61. Russia Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 62. Asia Pacific Nalmefene Sales Market Share by Purity (2016-2027)
Figure 63. Asia Pacific Nalmefene Revenue Market Share by Purity (2016-2027)
Figure 64. Asia Pacific Nalmefene Sales Market Share by Application (2016-2027)
Figure 65. Asia Pacific Nalmefene Revenue Market Share by Application (2016-2027)
Figure 66. Asia Pacific Nalmefene Sales Share by Region (2016-2027)
Figure 67. Asia Pacific Nalmefene Revenue Share by Region (2016-2027)
Figure 68. China Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 69. Japan Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 70. South Korea Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 71. India Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 72. Australia Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 73. China Taiwan Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 74. Indonesia Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 75. Thailand Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 76. Malaysia Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 77. Latin America Nalmefene Sales Market Share by Purity (2016-2027)
Figure 78. Latin America Nalmefene Revenue Market Share by Purity (2016-2027)
Figure 79. Latin America Nalmefene Sales Market Share by Application (2016-2027)
Figure 80. Latin America Nalmefene Revenue Market Share by Application (2016-2027)
Figure 81. Latin America Nalmefene Sales Share by Country (2016-2027)
Figure 82. Latin America Nalmefene Revenue Share by Country (2016-2027)
Figure 83. Mexico Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 84. Brazil Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 85. Argentina Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 86. Colombia Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 87. Middle East and Africa Nalmefene Sales Market Share by Purity (2016-2027)
Figure 88. Middle East and Africa Nalmefene Revenue Market Share by Purity (2016-2027)
Figure 89. Middle East and Africa Nalmefene Sales Market Share by Application (2016-2027)
Figure 90. Middle East and Africa Nalmefene Revenue Market Share by Application (2016-2027)
Figure 91. Middle East and Africa Nalmefene Sales Share by Country (2016-2027)
Figure 92. Middle East and Africa Nalmefene Revenue Share by Country (2016-2027)
Figure 93. Turkey Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 94. Saudi Arabia Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 95. UAE Nalmefene Revenue (2016-2027) & (US$ Million)
Figure 96. Nalmefene Value Chain
Figure 97. Nalmefene Production Process
Figure 98. Channels of Distribution
Figure 99. Distributors Profiles
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed